Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04681469
Title Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC (PRIME)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Gruppo Oncologico del Nord-Ovest
Indications

laryngeal squamous cell carcinoma

oropharynx cancer

hypopharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma

Therapies

Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST